Wednesday, September 3, 2025

September 03, 2025 at 03:54PM CDER/CBER Rare Disease Evidence Principles (RDEP)

CDER and CBER propose a new regulatory process for the approval of drugs to treat rare diseases with very small patient populations with significant unmet medical need.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/YgR2Cjp

No comments:

Post a Comment